Literature DB >> 25316442

IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells.

Rik A de Groen1, Arjan Boltjes, Jun Hou, Bi-Sheng Liu, Fiona McPhee, Jacques Friborg, Harry L A Janssen, André Boonstra.   

Abstract

With increasing interest in alternative options to interferon-alpha-based treatments, IFN-λ has shown therapeutic promise in a variety of diseases. Although the antiviral activity of IFN-λ has been extensively studied, there is limited knowledge regarding the immunological functions of IFN-λ and how these differ from those of other classes of IFNs. In this study, we investigated the effects of IFN-λ on primary human NK cells, both in a direct and indirect capacity. We demonstrate that in contrast to interferon-alpha, IFN-λ is unable to directly stimulate NK cells, due to the absence of IFN-λ receptor chain 1 (IFN-λR1) on NK cells. However, IFN-λ, in combination with TLR4 challenge, is able to induce the production of select members of the IL-12 family of cytokines in monocyte-derived macrophages. We further show that through macrophage-mediated IL-12 production, IFN-λ is able to indirectly affect NK cells and ultimately induce IFN-γ production.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Hepatitis C; IFN-γ; IL-29; Innate immunity; Macrophages; NK cells

Mesh:

Substances:

Year:  2014        PMID: 25316442     DOI: 10.1002/eji.201444903

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

Review 1.  Immunomodulation in leukemia: cellular aspects of anti-leukemic properties.

Authors:  M Maleknia; A Valizadeh; S M S Pezeshki; N Saki
Journal:  Clin Transl Oncol       Date:  2019-05-24       Impact factor: 3.405

Review 2.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

3.  IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function.

Authors:  Achille Broggi; Yunhao Tan; Francesca Granucci; Ivan Zanoni
Journal:  Nat Immunol       Date:  2017-08-28       Impact factor: 25.606

4.  BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.

Authors:  Aro Kim; Gyeongmin Lee; Ji-Hyeon Hwang; Jong-Hyeon Park; Min Ja Lee; Byounghan Kim; Su-Mi Kim
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

5.  Targeting IFN-λ Signaling Promotes Recovery from Central Nervous System Autoimmunity.

Authors:  Sindhu Manivasagam; Jessica L Williams; Lauren L Vollmer; Bryan Bollman; Juliet M Bartleson; Shenjian Ai; Gregory F Wu; Robyn S Klein
Journal:  J Immunol       Date:  2022-02-18       Impact factor: 5.426

6.  Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.

Authors:  Stephen R Goding; Shaohong Yu; Lisa M Bailey; Michael T Lotze; Per H Basse
Journal:  Clin Immunol       Date:  2016-07-01       Impact factor: 3.969

7.  Adenovirus expressing IFN-λ (Ad/hIFN-λ) produced anti-tumor effects through inducing apoptosis in human tongue squamous cell carcinoma cell.

Authors:  Bing Song; Yong Yang; Yan-Li Wang; Xiao-Hui Fan; Yu-Mei Huang; Hao-Su Ci; Jin-Hua Zuo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 8.  IFN-λ cancer immunotherapy: new kid on the block.

Authors:  Ahmed Lasfar; Helen Gogas; Andrew Zloza; Howard L Kaufman; John M Kirkwood
Journal:  Immunotherapy       Date:  2016-07       Impact factor: 4.196

Review 9.  Interferon-λ orchestrates innate and adaptive mucosal immune responses.

Authors:  Liang Ye; Daniel Schnepf; Peter Staeheli
Journal:  Nat Rev Immunol       Date:  2019-06-14       Impact factor: 53.106

10.  Inflammation response and liver stiffness: predictive model of regression of hepatic stiffness after sustained virological response in cirrhotics patients with chronic hepatitis C.

Authors:  Aline Márcia Marques Braz; Fernanda Cristina Winckler; Larissa Sarri Binelli; Luis Guilherme Chimeno; Lia Beatriz Mantovani Lopes; Rodrigo Santos Lima; Rafael Plana Simões; Rejane Maria Tommasini Grotto; Marjorie de Assis Golim; Giovanni Faria Silva
Journal:  Clin Exp Med       Date:  2021-04-09       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.